HC Wainwright & Co. Reiterates Buy on Denali Therapeutics, Maintains $105 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $105 price target.
HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $87 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Apellis Pharmaceuticals (NASDAQ:APLS) with a Buy and maintains $87 price target.
Needham Reiterates Buy on PowerSchool Holdings, Maintains $26 Price Target
Needham analyst Ryan MacDonald reiterates PowerSchool Holdings (NYSE:PWSC) with a Buy and maintains $26 price target.
Needham Reiterates Buy on Dun & Bradstreet Hldgs, Maintains $18 Price Target
Needham analyst Kyle Peterson reiterates Dun & Bradstreet Hldgs (NYSE:DNB) with a Buy and maintains $18 price target.
Telsey Advisory Group Reiterates Market Perform on Kohl’s, Maintains $35 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Kohl's (NYSE:KSS) with a Market Perform and maintains $35 price target.
Telsey Advisory Group Reiterates Outperform on Zevia, Maintains $5.5 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Zevia (NYSE:ZVIA) with a Outperform and maintains $5.5 price target.
Cowen & Co. Reiterates Outperform on Dutch Bros, Maintains $43 Price Target
Cowen & Co. analyst Andrew Charles reiterates Dutch Bros (NYSE:BROS) with a Outperform and maintains $43 price target.
Piper Sandler Reiterates Neutral on Olo, Maintains $9 Price Target
Piper Sandler analyst Clarke Jeffries reiterates Olo (NYSE:OLO) with a Neutral and maintains $9 price target.
Needham Reiterates Buy on Intel, Maintains $32 Price Target
Needham analyst Quinn Bolton reiterates Intel (NASDAQ:INTC) with a Buy and maintains $32 price target.
Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
Needham analyst Joseph Stringer reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $60 price target.